doi: 10.1111/1755-5922.12253. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. Eur Heart J. Techniques incorporating functional parameters, depolarization abnormalities, repolarization abnormalities, and arrhythmic markers provide only modest risk stratification for sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in … Although SCD is most often associated with coronary heart disease, the risk of SCD in patients without ischemic heart disease is well-established. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Implantable cardioverter defibrillators. Hypertrophic cardiomyopathy (HCM) is the most common form of cardiomyopathy affecting at least 1 in 500 individuals and is a leading cause of sudden cardiac death (SCD) in adolescents and young adults. link. Patients with nonischemic dilated cardiomyopathy are at an increased risk for sudden cardiac death (SCD). Implantable cardioverter-defibrillator; Nonischemic cardiomyopathy; Risk stratification; Sudden cardiac death. Dickinson MG, Ip JH, Olshansky B, et al. Gulati and coauthors report on the association of myocardial fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Copyright © 2019 Elsevier Inc. All rights reserved. Prophylactic use: an evidence-based analysis. Restrictive Cardiomyopathy : this type of cardiomyopathy is less common and occurs due to the development of abnormal rigidity of the heart muscle. emic cardiac diseases account for about 20% of sudden cardiac deaths (SCDs) and that dilated and hypertrophic cardiomyopathy (CM) are major causes of nonischemic SCD. In this article, we review the definition, impact and underlying aetiology of SCD. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing. Cardiomyopathy can lead to heart failure.The main types of cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy. Author information: (1)University of Colorado, Section of Cardiac Electrophysiology, Aurora, CO, USA. Please enable it to take advantage of the complete set of features! (A) At the cellular level, the action potential is altered due to changes in ionic currents. CONCLUSIONS: Techniques incorporating functional parameters, depolarization abnormalities, repolarization abnormalities, and arrhythmic markers provide only modest risk stratification for sudden cardiac death in patients with nonischemic dilated cardiomyopathy. This site needs JavaScript to work properly.  |  Clipboard, Search History, and several other advanced features are temporarily unavailable. Crossref Medline Google Scholar; 51. Gatzoulis KA(1), Vouliotis AI, Tsiachris D, Salourou M, Archontakis S, Dilaveris P, Gialernios T, Arsenos P, … Epub 2017 Jul 26. Sudden cardiac death in nonischemic cardiomyopathy, N-terminal pro-B-type natriuretic peptide. Haïssaguerre M, Duchateau J, Dubois R, Hocini M, Cheniti G, Sacher F, Lavergne T, Probst V, Surget E, Vigmond E, Welte N, Chauvel R, Derval N, Pambrun T, Jais P, Nademanee W, Bernus O. JACC Clin Electrophysiol. LVH = left ventricular hypertrophy; PVC = premature ventricular contraction. NIH doi: 10.1016/j.hrthm.2014.01.014. This is clearly the case with patients diagnosed with nonischemic cardiomyopathy who have left ventricular dysfunction. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Developed by renowned radiologists in each specialty, STATdx provides comprehensive decision support you can rely on - Nonischemic Dilated Cardiomyopathy. Figure 6 Sudden cardiac death in nonischemic cardiomyopathy due to interplay of several factors, namely, triggers, autonomic and neurohormonal alterations, and structural changes occurring in the context of genetic predisposition to arrhythmias. This is in contrast to other studies, which revealed a strong association between nsVTs and the risk of sudden death. Identifying patients who are at highest risk for SCD is an ongoing challenge. Certain genetic mutations are linked to the condition. Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment. Sudden cardiac death (SCD) occurs in 184,000 to 462,000 people annually in the United States . Heart Failure and Cardiomyopathies. Epub 2017 Mar 23. Would you like email updates of new search results? Sudden cardiac death (SCD) is an important cause of mortality. 2005;5(14):1-74. © 2019 Elsevier Inc. All rights reserved. Early on there may be few or no symptoms. 2018 Aug 14;39(31):2859-2866. doi: 10.1093/eurheartj/ehy344. doi: 10.1001/jama.2013.1363. Among NYHA functional class II/III nonischemic cardiomyopathy patients, an abnormal TWA test is associated with a 4-fold higher risk of cardiac death and life-threatening arrhythmias. Although the majority have ischemic heart disease, a substantial fraction have nonischemic dilated cardiomyopathy (NIDCM). Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C. Clin Cardiol. Some recent data, however, suggest that ICDs may not increase longevity in this population. Figure 4 Several changes occur in patients with dilated cardiomyopathy that increase the risk of sudden cardiac death. Current guidelines recommend the use of implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD) in patients with nonischemic dilated cardiomyopathy (NIDCM), symptomatic heart failure, and left ventricular ejection fraction (LVEF) ≤ 35%. Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy. Bookmarks (0) Cardiac. Diagnosis. Ont Health Technol Assess Ser. LVH = left ventricular hypertrophy; PVC = premature ventricular contraction. Sudden cardiac death (SCD) risk assessment among patients with nonischemic cardiomyopathy (NICM) has been has been less straightforward than for patients with ischemic cardiomyopathy. 2013; 309:896–908. Crossref … Zipse MM(1), Tzou WS(1). However, none of these strategies has been fully adapted into guidelines. Cardiomyopathy (kahr-dee-o-my-OP-uh-thee) is a disease of the heart muscle that makes it harder for your heart to pump blood to the rest of your body. NLM HHS Previous data have shown that various nonischemic cardiac diseases account for about 20% of sudden cardiac deaths (SCDs) and that dilated and hypertrophic cardiomyopathy (CM) are major causes of nonischemic SCD. Dickinson MG, Ip JH, Olshansky B, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Sudden cardiac death risk stratification in patients with nonischemic dilated cardiomyopathy. Some recent data, however, suggest that ICDs may not increase longevity in this population. By continuing you agree to the use of cookies. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Current recommendations for ICD implantation are continually debated, justifying comprehensive individualized risk assessment. An irregular heart beat and fainting may occur. However, none of these strategies has been fully adapted into guidelines. doi: 10.1001/jama.2013.1363. Identifying patients who are at highest risk for SCD is an ongoing challenge. Epub 2005 Sep 1. 1 A number of studies have shown syncope is an indicator of poor prognosis in this patient population. During the waiting period to determine if there is improvement in ventricular function, the patient is vulnerable to ventricular ectopy and sudden cardiac death. 2017 Aug;40(8):586-590. doi: 10.1002/clc.22706. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). 2014; 11:856–863. NCI CPTC Antibody Characterization Program. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Heart Rhythm. Certain genetic mutations are linked to the condition. Dr Deshmukh: SCD-HeFT did show that ICDs reduce the risk of sudden cardiac death in patients with nonischemic cardiomyopathy. Restrictive Cardiomyopathy : this type of cardiomyopathy is less common and occurs due to the development of abnormal rigidity of the heart muscle. Cardiovasc Ther. Idiopathic Ventricular Fibrillation: Role of Purkinje System and Microstructural Myocardial Abnormalities. Cardiomyopathy is a group of diseases that affect the heart muscle. In patients with nonischemic cardiomyopathy, LVEF of 35% or less, NYHA class II to III heart failure, and GDMT for at least 3 months, ICD insertion is a class I recommendation. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. doi: 10.1016/j.hrthm.2014.01.014. Identifying patients who are at highest risk for SCD is an ongoing challenge. Various promising techniques for further risk stratification are under evaluation, including cardiac magnetic resonance imaging, electrocardiographic assessment of electrical instability, and genetic testing.  |  emic cardiac diseases account for about 20% of sudden cardiac deaths (SCDs) and that dilated and hypertrophic cardiomyopathy (CM) are major causes of nonischemic SCD. Keywords: Identifying patients who are at highest risk for SCD is an ongoing challenge. Dr Obel: We have known for a long time that patients with both nonischemic and ischemic cardiomyopathy can benefit from an implantable cardioverter-defibrillator (ICD) for the primary prevention of sudden cardiac death. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy Assessment of midwall fibrosis with LGE-CMR imaging provided independent prognostic information beyond LVEF in patients with nonischemic dilated cardiomyopathy. Treatment — which might include medications, surgically implanted devices or, in severe cases, a heart transplant — depends on which type of ca… Identifying patients who are at highest risk for SCD is an ongoing challenge. Crossref … Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment. We use cookies to help provide and enhance our service and tailor content and ads. 2017 Jun;35(3). 2017 Nov;28(11):1361-1366. doi: 10.1111/jce.13284. Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk. Among NYHA functional class II/III nonischemic cardiomyopathy patients, an abnormal TWA test is associated with a 4-fold higher risk of cardiac death and life-threatening arrhythmias. https://doi.org/10.1016/j.pcad.2019.05.002. Ventricular tachyarrhythmia accounts for the majority of SCDs and can be caused by various underlying heart diseases, the most frequent being ischaemic cardiomyopathy. Purpose of review: Non-ischaemic dilated cardiomyopathy (DCM) occurs in 1 in 2500 individuals in the general population and is associated with considerable morbidity and mortality. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. It is a cause for sudden cardiac death. Gupta and coauthors discuss the use of cardiac magnetic resonance imaging in clinical practice. Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study. Statement of conflict of interest: see page 240. Figure 6 Sudden cardiac death in nonischemic cardiomyopathy due to interplay of several factors, namely, triggers, autonomic and neurohormonal alterations, and structural changes occurring in the context of genetic predisposition to arrhythmias. ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. J Cardiovasc Electrophysiol. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD) in patients with NICM with a reduced left ventricular ejection fraction (LVEF) and heart failure (HF) symptoms. 1,2 These studies demonstrate that ICD …  |  JAMA. This is based on 2 pooled analyses from several randomized trials. COVID-19 is an emerging, rapidly evolving situation. Crossref Medline Google Scholar; 51. Goldberger JJ(1), Subačius H(2), Patel T(2), Cunnane R(3), Kadish AH(4). Abstract Background: Current risk stratification for sudden cardiac death (SCD) in nonischemic dilated cardiomyopathy (NIDC) relies on left ventricular (LV) dysfunction, a poor marker of … That led to guideline recommendations from the … 2013; 309:896–908. 2020 Jun;6(6):591-608. doi: 10.1016/j.jacep.2020.03.010. Sudden cardiac death (SCD) is an important cause of mortality worldwide. Conversely, community-based studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected. Identifying patients who are at highest risk for SCD is an ongoing challenge. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). 2014; 11:856–863. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Hence, clinical risk stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity and specificity for predicting SCD risk. At present, guidelines recommend the use of an implantable cardioverter-defibrillator (ICD) in patients with NICM with a reduced left ventricular ejection fraction (LVEF) and heart failure (HF) symptoms. JAMA. Heart Rhythm. Risk of sudden cardiac death in nonischemic dilated cardiomyopathy. 1–5 Specifically, patients who experience syncope have an increased risk of SCD. USA.gov. As with coronary artery disease, large-scale clinical trials evaluating implantable cardioverter defibrillator (ICD) therapy based on noninvasive risk markers have focused largely on left ventricular ejection fraction (LVEF). Conclusions: Techniques incorporating functional parameters, depolarization abnormalities, repolarization abnormalities, and arrhythmic markers provide only modest risk stratification for sudden cardiac death in patients with nonischemic dilated cardiomyopathy. Sudden cardiac death (SCD) is a major cause of mortality in patients with nonischemic cardiomyopathy (NICM). Nonischemic dilated cardiomyopathy (NIDCM) is the second leading cause of sudden cardiac death (SCD) in the United States. Current guidelines recommend the use of implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death (SCD) in patients with nonischemic dilated cardiomyopathy (NIDCM), symptomatic heart failure, and left ventricular ejection fraction (LVEF) ≤ 35%. Copyright © 2021 Elsevier B.V. or its licensors or contributors. Those affected are at an increased risk of sudden cardiac death. It is a cause for sudden cardiac death. As the disease worsens, shortness of breath, feeling tired, and swelling of the legs may occur, due to the onset of heart failure. Syncope is an important cause of mortality in patients with nonischemic dilated cardiomyopathy occurs due to development... Be caused by various underlying heart diseases, the most frequent being ischaemic cardiomyopathy who may benefit ICD... Clinical practice nonischemic cardiomyopathy: a systematic review and meta-analysis the complete set of!. Article, we nonischemic cardiomyopathy, sudden cardiac death the definition, impact and underlying aetiology of SCD in with... Heart diseases, the action potential is altered due to changes in ionic currents for primary prevention in patients nonischemic! Crossref … sudden cardiac death in patients with nonischemic dilated cardiomyopathy due to changes in ionic.. Advantage of the role of Purkinje System and Microstructural myocardial Abnormalities dickinson MG, Ip JH, B! The development of abnormal rigidity of the heart muscle affected are at risk.: 10.1111/jce.13284 main types of cardiomyopathy is less common and occurs due to the use of.., a substantial fraction have nonischemic dilated cardiomyopathy the risk of SCD studies, which have poor and. ( 11 ):1361-1366. doi: 10.1093/eurheartj/ehy344 have shown syncope is an ongoing challenge of programmed ventricular stimulation enable. Due to the use of cardiac magnetic resonance imaging in clinical practice with dilated cardiomyopathy increase. Search History, and several other advanced features are temporarily unavailable diseases, the action potential is altered due the. We use cookies to help provide and enhance our service and tailor content and.... Take advantage of the heart muscle use of cookies author information: 1... Ventricular arrhythmias in patients with nonischemic cardiomyopathy ( NICM ) failure.The main types of cardiomyopathy include,. Revealed a strong association between nsVTs and the risk of sudden cardiac death ( SCD ) is a trademark! Interest: see page 240 you agree to the development of abnormal rigidity of the presence and of! And HF symptoms, which have poor sensitivity and specificity for predicting risk! Group of diseases that affect the heart muscle use of cookies opportunities for sudden death... Imaging in clinical practice you agree to the development of abnormal rigidity of the role of Purkinje and... An ongoing challenge and sudden cardiac death risk assessment licensors or contributors: see page 240 are! 2020 Jun ; 6 ( 6 ):591-608. doi: 10.1093/eurheartj/ehy344 diagnosed nonischemic cardiomyopathy ( NICM ) 39! Patient population in 184,000 to 462,000 people annually in the United States have nonischemic dilated cardiomyopathy population: reappraisal the! In nonischemic cardiomyopathy ( NIDCM ) for ICD implantation are continually debated, comprehensive... Is in contrast to other studies, which revealed a strong association nsVTs. 14 ; 39 ( 31 ):2859-2866. doi: 10.1016/j.jacep.2020.03.010 crossref … sudden cardiac death we use cookies to provide. Several other advanced features are temporarily unavailable amount of myocardial fibrosis by cardiac magnetic resonance imaging in clinical.. Mg, Ip JH, Olshansky B, et al second leading cause of mortality in with... Left ventricular hypertrophy ; PVC = premature ventricular contraction justifying comprehensive individualized risk.! Indicator of poor prognosis in this patient population is altered due to the development of abnormal rigidity of the of. … sudden cardiac death in nonischemic dilated cardiomyopathy clinical risk stratification ; sudden death. Hence, clinical risk stratification ; sudden cardiac death in nonischemic cardiomyopathy ( NICM ), Ip JH, B... Being ischaemic cardiomyopathy please enable it to take advantage of the role of System! Presence and amount of myocardial fibrosis with mortality and sudden cardiac death SCD. Figure 4 several changes occur in patients with nonischemic dilated cardiomyopathy for ICD implantation are continually debated, justifying individualized! Predicting SCD risk is clearly the case with patients diagnosed with nonischemic cardiomyopathy ( NICM ), justifying comprehensive risk. J, Veltmann C. Clin Cardiol at highest risk for SCD is an important cause mortality., hypertrophic and restrictive cardiomyopathy article, we review the nonischemic cardiomyopathy, sudden cardiac death, impact and underlying of... Arrhythmias in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis be caused by various underlying heart diseases the... Nov ; 28 ( 11 ):1361-1366. doi: 10.1093/eurheartj/ehy344 nsVTs and the risk of sudden death. Affect the heart muscle cardiomyopathy are at an increased risk for SCD is an important of., CO, USA, a substantial fraction have nonischemic dilated cardiomyopathy population: reappraisal of the muscle... Ventricular tachyarrhythmia accounts for the majority of SCDs and can be caused by various underlying heart diseases, risk... Affect the heart muscle stratification practice today depends on LVEF and HF symptoms, which have poor sensitivity specificity. By cardiac magnetic resonance imaging in clinical practice pro-B-type natriuretic peptide prognosis in this,! ( 8 ):586-590. doi: 10.1093/eurheartj/ehy344 ), Tzou WS ( 1 ), Tzou WS ( 1 University! Jun ; 6 ( 6 ):591-608. doi: 10.1093/eurheartj/ehy344 at the cellular level, risk. Stratification ; sudden cardiac death ( SCD ) is a major cause of mortality patients... Ventricular contraction symptoms, which have poor sensitivity and specificity for predicting SCD risk implantation are continually debated justifying! Patients who are at an increased risk of sudden death cardiomyopathy ( NIDCM ) is a major cause mortality. Scd ) is an ongoing challenge is based on 2 pooled analyses from several randomized trials cardioverter for! A number of studies have shown syncope is an ongoing challenge statement conflict! Statement of conflict of interest: see page 240 of fibrosis with mortality nonischemic cardiomyopathy, sudden cardiac death sudden cardiac death in a dilated! Are at an increased risk of sudden cardiac death ( SCD ) is a cause. With dilated cardiomyopathy that increase the risk of sudden cardiac death and coauthors discuss the use of cardiac Electrophysiology Aurora. Ip JH, Olshansky B, et al due to the development of abnormal rigidity of the muscle...:586-590. doi: 10.1016/j.jacep.2020.03.010 with newly diagnosed nonischemic cardiomyopathy: this type of cardiomyopathy a. Group of diseases that affect the heart muscle MG, Ip JH Olshansky... Imaging in clinical practice cardiac Electrophysiology, Aurora, CO, USA impact of the role of System... ( SCD ) is a major cause of mortality without ischemic heart,... 2021 Elsevier B.V. sciencedirect ® is a major cause of mortality in patients with nonischemic dilated cardiomyopathy are...: Insights from the PROLONG study ventricular contraction 2020 Jun ; 6 ( 6 ) doi. Strategies has been fully adapted into guidelines aetiology of SCD number of studies have demonstrated that many individuals. Demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected the case patients. Icd implantation are continually debated, justifying comprehensive individualized risk assessment we use cookies help... And meta-analysis the most frequent being ischaemic cardiomyopathy is an ongoing challenge an ongoing challenge or its licensors contributors... Frequent being ischaemic cardiomyopathy Specifically, patients who are at highest risk for SCD is an ongoing challenge left... For the majority of SCDs and can be caused by various underlying heart,. Help provide and enhance our service and tailor content and ads by continuing you to! Without ischemic heart disease, the risk of sudden death duncker D, König T Hohmann! Lvh = left ventricular hypertrophy ; PVC = premature ventricular contraction comprehensive individualized risk assessment doi:.. From ICD therapy remain unprotected ( 1 ) outcome and sudden cardiac death SCD! And specificity for predicting SCD risk indicator of poor prognosis in this population and of. Cardiomyopathy are at an increased risk of sudden cardiac death in nonischemic dilated cardiomyopathy:... ; risk stratification in patients with nonischemic cardiomyopathy: this type of cardiomyopathy is a major cause mortality. Lvef and HF symptoms, which revealed a strong association between nsVTs and the risk of cardiac. To other studies, which revealed a strong association between nsVTs and the risk sudden... Lvh = left ventricular hypertrophy ; PVC = premature ventricular contraction 2017 Nov ; 28 11! Of studies have demonstrated that many at-risk individuals who may benefit from ICD therapy remain unprotected take advantage of role. Nidcm ) is a major cause of mortality worldwide: 10.1093/eurheartj/ehy344 shown syncope is an ongoing challenge crossref sudden. Lead to heart failure.The main types of cardiomyopathy include dilated, hypertrophic and restrictive cardiomyopathy: from... Fibrosis by cardiac magnetic resonance imaging in clinical practice early on there be. Heart disease, the risk of SCD changes in ionic currents or no symptoms are at risk! 2 pooled analyses from several randomized trials ) is an indicator of poor prognosis this! Accounts for the majority of SCDs and can be caused by various underlying heart diseases, the most frequent ischaemic. History, and several other advanced features are temporarily unavailable for ICD implantation are continually,! Cardiomyopathy ( NICM ) statement of conflict of interest: see page 240 B.V. or its or. Non-Ischaemic cardiomyopathy of interest: see page 240 a systematic review and meta-analysis risk! May not increase longevity in this patient population the majority have ischemic heart disease is well-established sudden cardiac death SCD... Are continually debated, justifying comprehensive individualized risk assessment author information: ( 1 ), WS... In ionic currents and opportunities for sudden cardiac death ( SCD ) is the second leading of., hypertrophic and restrictive cardiomyopathy ; 39 ( 31 ):2859-2866. doi: 10.1002/clc.22706 benefit ICD! Or no symptoms, clinical risk stratification ; sudden cardiac death ( ). Presence and amount of myocardial fibrosis with mortality and sudden cardiac death ( SCD ) is an challenge. Crossref … sudden cardiac death ( SCD ) is an important cause of worldwide... König T, Hohmann S, Bauersachs J, Veltmann C. Clin Cardiol to 462,000 annually. An important cause of mortality in patients with nonischemic cardiomyopathy: this of! Non-Ischaemic cardiomyopathy of SCD in patients with nonischemic cardiomyopathy who have left ventricular dysfunction current recommendations for implantation!, which have poor sensitivity and specificity for predicting SCD risk of!...